CervoMed (CRVO) Assets (2010 - 2026)
CervoMed (CRVO) posted Assets of $15.1 million for Q1 2026, down 33.94% sequentially from $22.9 million in Q4 2025, and down 60.82% YoY from $38.6 million in Q1 2025.
CervoMed (CRVO) Assets (2010 - 2026) Analysis & Trends
CervoMed has reported Assets for 17 years, with the latest figure at $15.1 million in Q1 2026.
- Quarterly Assets fell 60.82% year-over-year to $15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (down 60.82% YoY) and the FY2025 annual result came in at $22.9 million, down 46.89% from the prior year.
- Assets declined to $15.1 million in Q1 2026 per CRVO's latest filing, from $22.9 million in the prior quarter.
- Over five years, Assets peaked at $53.2 million in Q2 2024 and troughed at $3.4 million in Q2 2023.
- A 5-year average of $24.8 million and a median of $26.3 million in 2022 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets sank 89.01% in 2022, then soared 1481.07% in 2024.
- Over 5 years, Assets stood at $4.2 million in 2022, then jumped by 139.86% to $10.0 million in 2023, then soared by 332.0% to $43.1 million in 2024, then tumbled by 46.89% to $22.9 million in 2025, then plunged by 33.94% to $15.1 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $15.1 million, $22.9 million, and $30.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | 25.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.99 Mn |
| Mar 31, 2026 | 15.11 Mn |
| Dec 31, 2025 | 22.88 Mn |
| Sep 30, 2025 | 30.61 Mn |
| Jun 30, 2025 | 38.08 Mn |
| Mar 31, 2025 | 38.58 Mn |
| Dec 31, 2024 | 43.08 Mn |
| Sep 30, 2024 | 48.88 Mn |
| Jun 30, 2024 | 53.19 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 9.97 Mn |
| Sep 30, 2023 | 12.04 Mn |
| Jun 30, 2023 | 3.36 Mn |
| Mar 31, 2023 | 3.94 Mn |
| Dec 31, 2022 | 4.16 Mn |
| Sep 30, 2022 | 26.32 Mn |
| Jun 30, 2022 | 29.18 Mn |
| Mar 31, 2022 | 33.57 Mn |
| Dec 31, 2021 | 37.84 Mn |
| Sep 30, 2021 | 40.88 Mn |